 | | |
|
|
|
|
|
|
News
Release: May 31, 2007
Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
KING OF PRUSSIA, PA, May 31 (HSMN NewsFeed) - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has named Dr. Todd Johnson to the position of Senior Vice-President for Strategy and Corporate Development. Dr. Johnson will lead efforts to accelerate profitable growth through strategic partnerships and acquisitions.
Before joining MDS, Dr. Johnson spent five years at McKinsey & Company, where he led strategic consulting engagements at several major pharmaceutical and biotech firms. Prior to that, he was CEO of Tangerine Technologies, a biotech software firm he founded in 1997. He started his career as a Cancer Biologist, conducting biomedical research at Harvard University's Dana-Farber Cancer Institute in Boston, the University of Pennsylvania in Philadelphia, and the National Institutes of Health in Bethesda.
"I am excited that Dr. Johnson has joined the MDS Pharma Services team to help drive our growth efforts," said MDS Pharma Services President David Spaight. "His expertise in medical research and consulting will help us to leverage industry trends to develop new services for our clients."
Educated at the University of Pennsylvania in Philadelphia, Dr. Johnson holds an MBA from its Wharton School, an MD from its Medical School, and a BA in Neurobiology from its College of Arts and Sciences' honors program. During his college career, he also studied Philosophy and Cognitive Neuroscience at St. Catherine's College of Oxford University in the United Kingdom.
About MDS Pharma Services
MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.ccom.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS ; NYSE: MDZ ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly skilled people in 28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
|
Source: MDS Pharma Services
Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.
|
 |
|
|
Public
Feeds 
